Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, OpenLabel, Multicenter Study Support Reduction in G-CSF Dosing

被引：2
|
作者：
Warren, Julia T. [1 ,2 ]
Dickerson, Kathryn E. [3 ]
Sharathkumar, Anjali A. [4 ]
Walter, Jolan E. [5 ]
Wilson, David B. [6 ]
Adell, Katrina P. [7 ]
Chen, Kelly [7 ]
Dubuc, Susan [7 ]
MacLeod, Rick [7 ]
Peters, Katie [7 ]
Stewart, Murray [7 ]
Taveras, Arthur G. [7 ]
Walkovich, Kelly [8 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Hematol & Oncol, Dallas, TX 75390 USA
[4] Univ Iowa Hlth Care, Stead Family Dept Pediat, Carver Coll Med, Iowa City, IA USA
[5] Univ S Florida, Johns Hopkins All Childrens Hosp, Morsani Coll Med, Div Allergy & Immunol,Dept Pediat, St Petersburg, FL USA
[6] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[7] X4 Pharmaceut Inc, Boston, MA USA
[8] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173549
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies
    F Awan
    S T Kochuparambil
    D E Falconer
    A Cumpston
    S Leadmon
    K Watkins
    D DeRemer
    A Jillella
    M Craig
    M Hamadani
    Bone Marrow Transplantation, 2013, 48 : 1279 - 1284
  • [32] CYCLOPHOSPHAMIDE (3.6 G/M(2)) THERAPY WITH G-CSF SUPPORT FOR RESISTANT MYELOMA
    PALUMBO, A
    BOCCADORO, M
    BRUNO, B
    TRIOLO, S
    PILERI, A
    HAEMATOLOGICA, 1994, 79 (06) : 513 - 518
  • [33] Higher efficacy of intermediate dose cytarabine plus G-CSF compared to cyclophosphamide plus G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma
    Bogucka-Fedorczuk, Aleksandra
    Czyz, Anna
    Kalicinska, Elzbieta
    Sawicki, Mateusz
    Laszkowska-Lewko, Magdalena
    Wicherska-Pawlowska, Katarzyna
    Rybka, Justyna
    Szeremet, Agnieszka
    Prajs, Iwona
    Szymczak, Donata
    Wrobel, Tomasz
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (04) : 246 - 254
  • [34] Exploring Erythropoietin and G-CSF Combination Therapy in Chronic Stroke Patients
    Shin, Yoon-Kyum
    Cho, Sung-Rae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04)
  • [35] Increased Efficacy of Chemomobilization with Intermediate Dose Cytarabine plus G-CSF Compared to G-CSF Alone for Patients with Multiple Myeloma: Results of a Prospective, Randomized Trial
    Czerw, Tomasz
    Mendrek, Wlodzimierz
    Najda, Jacek
    Sobczyk-Kruszelnicka, Malgorzata
    Sadus-Wojciechowska, Maria
    Soska, Katarzyna
    Glowala-Kosinska, Magdalena
    Chwieduk, Agata
    Fidyk, Wojciech
    Holowiecki, Jerzy
    Giebel, Sebastian
    BLOOD, 2016, 128 (22)
  • [36] IS LOW DOSE CYCLOPHOSPHAMIDE PLUS G-CSF MOBLIZATION AS EFFECTIVE AS MOZOBIL (PLERIXAFOR) PLUS G-CSF IN MULTIPLE MYELOMA (MM) PATIENTS ELIGIBLE FOR TANDEM TRANSPLANT?
    Karanes, C.
    Dagis, A.
    Wang, S.
    Krishnan, A.
    Sahebi, F.
    Popplewell, L.
    Parker, P.
    Forman, S.
    Palmer, J.
    Kogut, N.
    Somlo, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S205 - S206
  • [37] Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients
    Kröger, N
    Zeller, W
    Fehse, N
    Hassan, HT
    Krüger, W
    Gutensohn, K
    Lölliger, C
    Zander, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (04) : 1101 - 1106
  • [38] A Comparison of Chemotherapy plus G-CSF Versus Plerixafor (Mazobil®) plus G-CSF for Stem Cell Mobilization In Patients with Multiple Myeloma Treated with Lenalidomide.
    Mark, Tomer M.
    Rossi, Adriana C.
    Pearse, Roger N.
    Coleman, Morton
    Bernstein, David
    Zafar, Faiza
    Dergis, Usama
    Shore, Tsiporah B.
    Niesvizky, Ruben
    BLOOD, 2010, 116 (21) : 928 - 929
  • [39] Inefficiency of high dose G-CSF alone as 2nd mobilization regimen in FLU-Cy treated CLL patients failed to mobilize after CY plus G-CSF
    Jindra, P
    Koza, V
    Lysak, D
    Vozobulova, V
    Cema, K
    Karas, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S257 - S258
  • [40] INTRAORAL RESPONSES TO HUMAN G-CSF THERAPY IN CHRONIC NEUTROPENIA PATIENTS
    LOOS, PJ
    STEWART, JCB
    BOXER, LA
    JOURNAL OF DENTAL RESEARCH, 1990, 69 : 219 - 219
12345